Equitec Proprietary Markets’s LAVA Therapeutics LVTX Stock Holding History

Equitec Proprietary Markets’s Portfolio LVTX Stock Details LVTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-12,500	Closed	-$19.5K	–	97
2025 Q3	$19.5K	Buy	+12,500	New	+$18.7K	﹤0.01%	47

Equitec Proprietary Markets's LVTX Position: Q4 2025 in Review

Equitec Proprietary Markets sold out of LAVA Therapeutics (LVTX) in Q4 2025, closing a stake of 12,500 shares — an estimated $19.5K sold.

Equitec Proprietary Markets first reported a position in LVTX in Q3 2025 and held it in 1 quarter. The position peaked at $19.5K in Q3 2025. 0 funds tracked by Wall St. Rank hold LVTX as of Q4 2025.

Equitec Proprietary Markets reported no remaining LAVA Therapeutics position as of Q4 2025 after selling out during the quarter.
Equitec Proprietary Markets sold 12,500 LAVA Therapeutics shares in Q4 2025, an estimated $19.5K.
Equitec Proprietary Markets first reported a position in LAVA Therapeutics in Q3 2025 and held it in 1 quarter.
Equitec Proprietary Markets's LAVA Therapeutics position peaked at $19.5K in Q3 2025.
0 funds tracked by Wall St. Rank held LAVA Therapeutics as of Q4 2025.

Based on Equitec Proprietary Markets's 13F filing for Q4 2025, filed 17 Feb 2026.